Hepatitis C virus (HCV) is classified within the genus hepacivirus, and belongs to the family flaviviridae. HCV causes both acute and chronic infection. Acute HCV infections are usually asymptomatic and most do not lead to a life-threatening disease. Around 30% (15–45%) of infected persons spontaneously clear the virus within 6 months of infection without any treatment. The remaining 70% (55–85%) of persons will develop chronic HCV infection. Of those with chronic HCV infection, the risk of cirrhosis ranges from 15% to 30% within 20 years.
Merimepodib
From $105
Mizoribine
From $75
MK-5172
From $90
MK-5172 (potassium salt)
From $90
MK-5172 Sodium Salt
From $90
Narlaprevir
From $115
Nesbuvir
From $135
Nucleoside-Analog-1
From $130
Nucleoside-Analog-2
From $130
PSI-6130
From $125
PSI-6206
From $80
PSI-6206 13CD3
From $750
PSI-7976
From $1,965
R-1479
From $130
R-7128
From $115
Resiquimod
From $98
Ribavirin
From $75
RO-9187
From $125
RO8191
From $415
Simeprevir
From $85
Sofosbuvir D6
From $1,090
